Essential Role for Survivin in the Proliferative Expansion of Progenitor and Mature B Cells-Reference-Cited by-同舟云学术

Essential Role for Survivin in the Proliferative Expansion of Progenitor and Mature B Cells

Published:2016-01-25 Issue:5 Volume:196 Page:2195-2204
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J.I.

Author:

Miletic Ana V.^ORCID,Jellusova Julia,Cato Matthew H.,Lee Charlotte R.,Baracho Gisele V.^ORCID,Conway Edward M.,Rickert Robert C.

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference27 articles.

1. IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs.;Tamm;Cancer Res.,1998

2. An Anti-apoptotic Protein Human Survivin Is a Direct Inhibitor of Caspase-3 and -7

3. Mita, A. C., M. M. Mita, S. T. Nawrocki, and F. J. Giles. 2008. Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics. Clin. Cancer Res. 14: 5000–5005.

4. The chromosomal passenger complex (CPC): from easy rider to the godfather of mitosis

5. Deconstructing Survivin: comprehensive genetic analysis of Survivin function by conditional knockout in a vertebrate cell line

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interaction of SMAC with a survivin-derived peptide alters essential cancer hallmarks: Tumor growth, inflammation, and immunosuppression;Molecular Therapy;2024-06

2. Survivin as a Therapeutic Target for the Treatment of Human Cancer;Cancers;2024-04-27

3. BCL2 Protein Progressively Declines during Robust CLL Clonal Expansion: Potential Impact on Venetoclax Clinical Efficacy and Insights on Mechanism;Lymphatics;2024-03-28

4. Cancer Resistance Is Mediated by the Upregulation of Several Anti-Apoptotic Gene Products via the Inducible Nitric Oxide Synthase/Nitric Oxide Pathway: Therapeutic Implications;Antioxidants & Redox Signaling;2023-11-01

5. Multiple functions and regulatory network of miR-150 in B lymphocyte-related diseases;Frontiers in Oncology;2023-04-27